Firma Tentamus Group, Autor bei Presse-Blog

TentaConsult erhält ISO 13485 Zertifizierung und erneuert ISO 9001 Zertifikat

15. April 2026 Firma Tentamus GroupDienstleistungenHumanarzneimittel, ISO 13485, ISO 9001, konformitätsbewertung, Marktzugang, mdr, medizinprodukte, Post-Market Surveillance, qualitätsmanagement, Re-Zertifizierung, regulatorische Beratung, technische dokumentation, tentaconsult, zertifizierung

TentaConsult Pharma & Med hat die Re Zertifizierung nach ISO 9001 erfolgreich abgeschlossen und darüber hinaus erstmals die Zertifizierung nach ISO 13485 erhalten. Beide Zertifikate gelten bis 2029. Für das Unternehmen ist dies weit mehr als ein formaler Nachweis. In Mehr

IFS Local Check: How Quant Helps Small Food Businesses Enter the Retail Market

14. April 2026 Firma Tentamus GroupDienstleistungenartisanal producers, corrective actions, family businesses, food businesses, food safety, haccp, Hygiene, IFS Local Check, labeling, Market Access, Product Safety, retail market, retailer approval, storage

The IFS Local Check now offers small food producers, family businesses, and artisanal manufacturers a valuable opportunity to implement the fundamentals of food safety and product safety in a structured way. Although the check is not a formal certification, it Mehr

Analytical Food Laboratories Enhances Testing Capabilities with Advanced CEM Instrumentation

9. April 2026 Firma Tentamus GroupForschung und Entwicklungadvanced instrumentation, analytical reliability, analytical testing, CEM Corporation, faster turnaround times, fat determination, food testing, laboratory efficiency, moisture analysis, NMR technology, oracle, SMART 6, solids analysis, solvent-free testing, standardized methods

Analytical Food Laboratories (AFL), a Tentamus Company, announced the addition of two advanced analytical instruments from CEM Corporation, significantly enhancing its capabilities in moisture, solids, and fat analysis. The integration of the SMART 6™ and ORACLE™ systems enables faster, more Mehr

Beyond the attention war: How TECHNI’SENS secures research integrity and data reliability for international brands

2. April 2026 Firma Tentamus GroupForschung und Entwicklungactionable insights, attention management, behavioral indicators, cognitive science, consumer research, data reliability, quality control, reproducibility of results, research integrity, respondent inattention, sensory testing, statistical noise, statistical robustness, survey methodology, survey satisficing

While digital noise fragments consumers‘ attention, French research institute TECHNI’SENS integrates cognitive science to strengthen data integrity. With research showing that 10% to 12% of respondents can be considered inattentive depending on the detection methods used (Meade & Craig, 2012), Mehr

Renolab offers new testing services for biopesticides

26. März 2026 Firma Tentamus GroupBiotechnikbiological control, Biopesticides, biostimulants, contaminant quantification, Crop Protection, Five Batch Analysis, formulation testing, microbial strains, microbiological analysis, one-health, physico-chemical analysis, quality control, Regulatory Compliance, stability studies, sustainable agriculture

Biopesticides are among the most promising solutions to promote sustainable agriculture and reduce dependence on synthetic pesticides. Based on microorganisms, natural metabolites or substances of plant or animal origin, these products help protect crops while reducing environmental impact and food Mehr

GMW Bioscience Joins the Tentamus Group

5. März 202611. März 2026 Firma Tentamus GroupBiotechnikagribiotechnology, Agricultural Innovation, biological control, bioscience services, biostimulants, Contract Research Organization, cro, efficacy trials, field trials, GMW Bioscience, iberia, Regulatory Compliance, spain, Tentamus Group, valencia

GMW Bioscience, a Contract Research Organization (CRO) specializing in efficacy trials, biostimulants, and agribiotechnology services, has officially joined the Tentamus Group. As a trusted expert partner, GMW Bioscience supports its clients by conducting controlled and field trials covering efficacy, biostimulant, Mehr

Tentamus Group Appoints David Biacsi-Schoen as Head of Group IT and Director IT DACH

27. Februar 20265. März 2026 Firma Tentamus GroupFirmeninternbusiness alignment, Digitalization, Director IT DACH, governance, Head of Group IT, healthcare technology, information security, infrastructure, innovation, IT-Leadership, operational reliability, regional initiatives, Scalability

The Tentamus Group is pleased to announce that David Biacsi-Schoen will join the company effective March 1, 2026, assuming the dual roles of Head of Group IT and Director IT DACH. In his role as Director IT DACH, David will Mehr

Tentamus Group appoints Eva-Aster de Gier as Chief Operating Officer

27. Februar 20265. März 2026 Firma Tentamus GroupFirmeninternchief operating officer, continuous improvement, COO, Digitalization, efficiency, Executive Management, global teams, Group IT, Operational Excellence, procurement, quality, Scalability, sustainable growth

We’re pleased to announce that Eva-Aster de Gier will be appointed Chief Operating Officer (COO) effective March 1, 2026. Eva-Aster previously served as Tentamus’ Director of Operations, where she played a pivotal role in building our operational excellence network, modernizing Mehr

Laemmegroup Launches Major Expansion to Strengthen Laboratory Efficiency and Analytical Excellence

26. Februar 20264. März 2026 Firma Tentamus GroupForschung und Entwicklungcompliance, efficiency, ergonomics, excellence, expansion, Good Laboratory Practices, homogenization, integration, preparation, Prioritization, reliability, representativeness, ventilation, Workflow, workstations

Laemmegroup Laboratory has initiated a major operational expansion aimed at delivering an even more efficient, faster, and more reliable service to its clients. The entire operational workflow has been comprehensively redesigned, from sample receipt through to the issuance of analytical Mehr

Implementation of a bioanalytical control device for routine measurement of drug products at VelaLabs

12. Februar 202625. Februar 2026 Firma Tentamus GroupBiotechnikassay development, automated cartridge-based system, bioanalytical control, biological drug substances, capillary electrophoresis, capillary isoelectric focusing, CE-SDS, charge analysis, cIEF, IgG antibodies, Maurice device, method transfer (Sciex), monoclonal antibodies, SDS-PAGE, size analysis

Bioanalytical control of biological drug substances is performed at VelaLabs using new capillary electrophoresis sodium dodecyl sulphate (CE-SDS) and capillary isoelectric focusing (cIEF) technology for charge and size analysis. In 2025, VelaLabs (Vienna) performed multiple assay developments for monoclonal antibodies Mehr

Autor: Firma Tentamus Group